Medline, Inc. MDLN Weighted Average Exercise Price of Outstanding Options

Weighted Average Exercise Price of Outstanding Options at other companies

Henry ScheinHSIC

$73.24—

UFP TechnologiesUFPT

$75.26—

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$33.35B+17.5%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's weighted average exercise price of outstanding options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's weighted average exercise price of outstanding options?: Medline, Inc. (MDLN) reported weighted average exercise price of outstanding options of $29.00 in Q1 2026.
What does weighted average exercise price of outstanding options mean?: This metric calculates the average price at which holders of outstanding stock options can purchase company shares. It provides context on the 'in-the-money' status of employee compensation packages. When compared to the current market price, it helps assess the alignment between employee incentives and shareholder value.